Latest & greatest articles for loratadine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on loratadine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on loratadine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for loratadine

1. Loratadine

Loratadine Top results for loratadine - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for loratadine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. Adverse effects of mizolastine, dextromethorphan, desloratadine and loratadine

Adverse effects of mizolastine, dextromethorphan, desloratadine and loratadine Prescrire IN ENGLISH - Spotlight ''In the September issue of Prescrire International: adverse effects of mizolastine, dextromethorphan, desloratadine and loratadine'', 1 September 2016 {1} {1} {1} | | > > > In the September issue of Prescrire International: adverse effects of mizolastine, dextromethorphan, desloratadine and loratadine Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent (...) :  |   |   |   |   |   |   |   |   |  Spotlight In the September issue of Prescrire International: adverse effects of mizolastine, dextromethorphan, desloratadine and loratadine FREE DOWNLOAD This sample page from the September edition contains three brief reviews analysing the adverse effects of several frequently prescribed antihistamines and antitussive medicines. Full text available for free download. Mizolastine: prefer

2016 Prescrire

3. Loratadine

Loratadine USE OF LORATADINE IN PREGNANCY 0344 892 0909 USE OF LORATADINE IN PREGNANCY (Date of issue: November 2018 , Version: 3 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Loratadine is a non-sedating antihistamine used for the symptomatic (...) relief of allergic conditions including rhinitis (hay fever) and chronic idiopathic urticaria. The available data do not provide evidence that loratadine use in pregnancy is associated with an increase in overall congenital malformation rate amongst exposed offspring. A single study has suggested an association between first trimester loratadine exposure and an increased risk of hypospadias in male infants, but more recent studies, which together describe the outcomes of a large number of exposed

2014 UK Teratology Information Service

4. [Evaluation of efficacy and safety of loratadine in the treatment of childhood asthma]. (Abstract)

[Evaluation of efficacy and safety of loratadine in the treatment of childhood asthma]. To evaluate the efficacy and safety of loratadine, a new generation of antihistaminics, in the treatment of childhood asthma.The papers related to loratadine treatment for childhood asthma were searched in the database of PubMed, MEDLINE, EMBASE, Cochrance, CNKI and CBMdisc (January 1990 to December 2010) electronically and manually. According to the Cochrane reviewer's handbook, the quality of the enrolled (...) papers was assessed and a systematic review was performed.A total of 179 papers were obtained. Eleven randomized controlled trials met the criteria and were included in this study. The 11 trials included 317 children with asthma: 159 cases in the loratadine treatment group and 158 cases in the control group. All included studies belonged to the B class according to the quality evaluation criteria. Meta analysis showed that the clinical symptoms were improved more, the forced expiratory volume in 1

2013 Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics

5. The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. (Full text)

The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis--a meta-analysis. Oral antihistamines are considered the gold standard therapy for allergic rhinitis to date. The goal of this investigation is to make an indirect comparison between loratadine, an oral antihistamine available over-the-counter (OTC) in the USA, and the more modern antihistamine levocetirizine. Only double-blind, placebo-controlled (DBPC) studies involving monotherapy (...) with the active substances levocetirizine and loratadine were included in the meta-analysis.The medical databases EMBASE and Medline were searched systematically for all relevant studies completed by the end of 2009. Only DBPC studies conducted in normal environmental settings were included. Furthermore, the Jadad scale was used to guarantee the quality of the studies involved. The "standardized mean difference" (SMD) method was applied for calculating the study-specific effects to neutralize the variability

2011 Allergology international : official journal of the Japanese Society of Allergology PubMed abstract

6. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. (Abstract)

Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis. Loratadine, a second-generation antihistamine, is commonly used to treat seasonal allergies. Some studies have suggested that use of loratadine by pregnant women increases the risk of hypospadias in male offspring.This meta-analysis was designed to assess the strength of the association between loratadine and hypospadias.To locate pertinent articles published in any language from (...) January 1989 until August 2007, we searched electronic databases (MEDLINE, OVID, EMBASE, SCOPUS, TOXLINE Special, ReproTox, TERIS, CINAHL and others), conference proceedings and bibliographies. Studies were eligible for this analysis if they were cohort, case-control or case series studies that reported the incidence of hypospadias in the offspring of women who were or were not exposed to loratadine during pregnancy. Two authors independently extracted information on study design, participant

2008 Drug safety : an international journal of medical toxicology and drug experience

7. Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis

Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis Risk of hypospadias in offspring of women using loratadine during pregnancy: a systematic review and meta-analysis Schwarz E B, Moretti M E, Nayak S, Koren G CRD summary The review concluded that the use of loratadine (a second generation antihistamine) during (...) pregnancy did not significantly increase the risk of hypospadias in male offspring. This seems to be a reasonable interpretation of the evidence and the authors' conclusion is likely to be reliable. Authors' objectives To determine the risk of hypospadias (congenital defect in the position of the urethra opening on the penis) in male offspring of women who received loratadine (a second generation antihistamine) during pregnancy. Searching The following databases were searched from January 1989 to May

2008 DARE.

8. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis. (Abstract)

Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis. Few randomized studies have compared the efficacy of ebastine and loratadine in the symptomatic treatment of seasonal allergic rhinitis (SAR).A meta-analysis was performed on data from four randomized, double-blind, placebo-controlled, parallel-group clinical trials comparing the efficacy of ebastine 20 mg once daily versus loratadine 10 mg once (...) daily in the symptomatic treatment of SAR symptoms. Primary efficacy variable was the mean change in the overall mean daily reflective total symptom score (TSS), i.e. the sum of five rhinitis symptom scores: nasal discharge, nasal congestion, nasal itching, sneezing and total eye symptoms (itchy/watery eyes) over the first 2 weeks of treatment compared to baseline.There were 2,089 patients in the population analyzed: 749, 739 and 601 patients in the ebastine 20 mg, loratadine 10 mg and placebo

2005 International archives of allergy and immunology

9. Loratadine in the high performance aerospace environment. (Abstract)

Loratadine in the high performance aerospace environment. Authors have unanimously reported that 10 mg of loratadine does not produce sedation. A small risk of sedation may exist and may not have been discovered by those studies due to their small sample size.Using combined data, there is no increased risk of sedation over placebo for patients using 10 mg of loratadine daily.Literature search and meta-analysis of published data was performed.Pooled data showed sedation in 25 of 517 patients (...) given 10 mg of loratadine, and 24 of 510 patients given placebo. The relative risk was 1.03, with a confidence interval from 0.59 to 1.77. Sleepiness was objectively studied using the multiple sleep latency test. Patients treated with 10 mg of loratadine did not have excess sleepiness induced; patients treated with 40 mg of loratadine did. Using 10 different methods, 20 studies did not find performance impairment in subjects given 10 mg of loratadine. Two performance studies, digit substitution

1999 Aviation, space, and environmental medicine